Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Author Correction: Inhibiting PD-L1 palmitoylation enhances T-cell immune responses against tumours

The Original Article was published on 25 March 2019

Correction to: Nature Biomedical Engineering https://doi.org/10.1038/s41551-019-0375-6, published online 25 March 2019.

In the version of this Article originally published, ‘palmitoyltransferase ZDHHC3 (DHHC3)’ was incorrectly referred to as an ‘acetyltransferase’ rather than an as an ‘acyltransferase’; this has now been corrected in five instances. In Fig. 3a, the label for the bottom row of the blots was mistakenly written as ‘GAPHD’; it should have read ‘GAPDH’. In the two right-most panels of Fig. 4j, the antibody labels ‘α-PD-L1’ for the reciprocal co-immunoprecipitation of DHHC3 were incorrect; they should have been ‘α-DHHC3’. These errors have been corrected in all versions of the Article.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Jie Xu.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Yao, H., Lan, J., Li, C. et al. Author Correction: Inhibiting PD-L1 palmitoylation enhances T-cell immune responses against tumours. Nat Biomed Eng 3, 414 (2019). https://doi.org/10.1038/s41551-019-0402-7

Download citation

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing